The Critical Interspecies Transmission Barrier at the Animal⁻Human Interface.
Identifieur interne : 000146 ( PubMed/Curation ); précédent : 000145; suivant : 000147The Critical Interspecies Transmission Barrier at the Animal⁻Human Interface.
Auteurs : Kanta Subbarao [Australie]Source :
- Tropical medicine and infectious disease [ 2414-6366 ] ; 2019.
Abstract
Influenza A viruses (IAVs) infect humans and a wide range of animal species in nature, and waterfowl and shorebirds are their reservoir hosts. Of the 18 haemagglutinin (HA) and 11 neuraminidase (NA) subtypes of IAV, 16 HA and 9 NA subtypes infect aquatic birds. However, among the diverse pool of IAVs in nature, only a limited number of animal IAVs cross the species barrier to infect humans and a small subset of those have spread efficiently from person to person to cause an influenza pandemic. The ability to infect a different species, replicate in the new host and transmit are three distinct steps in this process. Viral and host factors that are critical determinants of the ability of an avian IAV to infect and spread in humans are discussed.
DOI: 10.3390/tropicalmed4020072
PubMed: 31027299
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000146
Links to Exploration step
pubmed:31027299Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">The Critical Interspecies Transmission Barrier at the Animal⁻Human Interface.</title>
<author><name sortKey="Subbarao, Kanta" sort="Subbarao, Kanta" uniqKey="Subbarao K" first="Kanta" last="Subbarao">Kanta Subbarao</name>
<affiliation wicri:level="1"><nlm:affiliation>WHO Collaborating Centre for Reference and Research on Influenza and Department of Microbiology and Immunology, University of Melbourne, Peter Doherty Institute for Infection and Immunity, 792 Elizabeth Street, Melbourne, VIC 3000, Australia. kanta.subbarao@influenzacentre.org.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>WHO Collaborating Centre for Reference and Research on Influenza and Department of Microbiology and Immunology, University of Melbourne, Peter Doherty Institute for Infection and Immunity, 792 Elizabeth Street, Melbourne, VIC 3000</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2019">2019</date>
<idno type="RBID">pubmed:31027299</idno>
<idno type="pmid">31027299</idno>
<idno type="doi">10.3390/tropicalmed4020072</idno>
<idno type="wicri:Area/PubMed/Corpus">000146</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000146</idno>
<idno type="wicri:Area/PubMed/Curation">000146</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000146</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">The Critical Interspecies Transmission Barrier at the Animal⁻Human Interface.</title>
<author><name sortKey="Subbarao, Kanta" sort="Subbarao, Kanta" uniqKey="Subbarao K" first="Kanta" last="Subbarao">Kanta Subbarao</name>
<affiliation wicri:level="1"><nlm:affiliation>WHO Collaborating Centre for Reference and Research on Influenza and Department of Microbiology and Immunology, University of Melbourne, Peter Doherty Institute for Infection and Immunity, 792 Elizabeth Street, Melbourne, VIC 3000, Australia. kanta.subbarao@influenzacentre.org.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>WHO Collaborating Centre for Reference and Research on Influenza and Department of Microbiology and Immunology, University of Melbourne, Peter Doherty Institute for Infection and Immunity, 792 Elizabeth Street, Melbourne, VIC 3000</wicri:regionArea>
</affiliation>
</author>
</analytic>
<series><title level="j">Tropical medicine and infectious disease</title>
<idno type="eISSN">2414-6366</idno>
<imprint><date when="2019" type="published">2019</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Influenza A viruses (IAVs) infect humans and a wide range of animal species in nature, and waterfowl and shorebirds are their reservoir hosts. Of the 18 haemagglutinin (HA) and 11 neuraminidase (NA) subtypes of IAV, 16 HA and 9 NA subtypes infect aquatic birds. However, among the diverse pool of IAVs in nature, only a limited number of animal IAVs cross the species barrier to infect humans and a small subset of those have spread efficiently from person to person to cause an influenza pandemic. The ability to infect a different species, replicate in the new host and transmit are three distinct steps in this process. Viral and host factors that are critical determinants of the ability of an avian IAV to infect and spread in humans are discussed.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">31027299</PMID>
<DateRevised><Year>2020</Year>
<Month>02</Month>
<Day>25</Day>
</DateRevised>
<Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2414-6366</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>4</Volume>
<Issue>2</Issue>
<PubDate><Year>2019</Year>
<Month>Apr</Month>
<Day>25</Day>
</PubDate>
</JournalIssue>
<Title>Tropical medicine and infectious disease</Title>
<ISOAbbreviation>Trop Med Infect Dis</ISOAbbreviation>
</Journal>
<ArticleTitle>The Critical Interspecies Transmission Barrier at the Animal⁻Human Interface.</ArticleTitle>
<ELocationID EIdType="pii" ValidYN="Y">E72</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.3390/tropicalmed4020072</ELocationID>
<Abstract><AbstractText>Influenza A viruses (IAVs) infect humans and a wide range of animal species in nature, and waterfowl and shorebirds are their reservoir hosts. Of the 18 haemagglutinin (HA) and 11 neuraminidase (NA) subtypes of IAV, 16 HA and 9 NA subtypes infect aquatic birds. However, among the diverse pool of IAVs in nature, only a limited number of animal IAVs cross the species barrier to infect humans and a small subset of those have spread efficiently from person to person to cause an influenza pandemic. The ability to infect a different species, replicate in the new host and transmit are three distinct steps in this process. Viral and host factors that are critical determinants of the ability of an avian IAV to infect and spread in humans are discussed.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Subbarao</LastName>
<ForeName>Kanta</ForeName>
<Initials>K</Initials>
<AffiliationInfo><Affiliation>WHO Collaborating Centre for Reference and Research on Influenza and Department of Microbiology and Immunology, University of Melbourne, Peter Doherty Institute for Infection and Immunity, 792 Elizabeth Street, Melbourne, VIC 3000, Australia. kanta.subbarao@influenzacentre.org.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2019</Year>
<Month>04</Month>
<Day>25</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>Switzerland</Country>
<MedlineTA>Trop Med Infect Dis</MedlineTA>
<NlmUniqueID>101709042</NlmUniqueID>
<ISSNLinking>2414-6366</ISSNLinking>
</MedlineJournalInfo>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">animal–human interface</Keyword>
<Keyword MajorTopicYN="N">cross-species infection</Keyword>
<Keyword MajorTopicYN="N">influenza</Keyword>
<Keyword MajorTopicYN="N">species barrier</Keyword>
<Keyword MajorTopicYN="N">zoonoses</Keyword>
</KeywordList>
<CoiStatement>The author declares no conflict of interest.</CoiStatement>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year>
<Month>03</Month>
<Day>18</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2019</Year>
<Month>04</Month>
<Day>12</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2019</Year>
<Month>04</Month>
<Day>23</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2019</Year>
<Month>4</Month>
<Day>28</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2019</Year>
<Month>4</Month>
<Day>28</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2019</Year>
<Month>4</Month>
<Day>28</Day>
<Hour>6</Hour>
<Minute>1</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">31027299</ArticleId>
<ArticleId IdType="pii">tropicalmed4020072</ArticleId>
<ArticleId IdType="doi">10.3390/tropicalmed4020072</ArticleId>
<ArticleId IdType="pmc">PMC6630566</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>J Virol. 2000 Sep;74(18):8502-12</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10954551</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Vet Diagn Invest. 2003 Jan;15(1):30-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12580292</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2004 Mar 30;101(13):4620-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15070767</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Rev Microbiol. 2004 Nov;2(11):909-14</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15494747</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Virology. 1992 May;188(1):408-13</Citation>
<ArticleIdList><ArticleId IdType="pubmed">1566583</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Rev Microbiol. 2005 Aug;3(8):591-600</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16064053</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2005 Sep;79(18):12058-64</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16140781</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 2005 Oct 21;310(5747):482-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16186182</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>EMBO J. 1992 Jul;11(7):2407-14</Citation>
<ArticleIdList><ArticleId IdType="pubmed">1628614</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nature. 2006 Mar 23;440(7083):435-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16554799</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 2006 Apr 21;312(5772):399</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16556800</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2006 Aug 8;103(32):12121-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16880383</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Rev Immunol. 2007 Apr;7(4):267-78</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17363960</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Biotechnol. 2008 Jan;26(1):107-13</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18176555</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS One. 2008 Aug 13;3(8):e2923</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18698430</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):3366-71</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19211790</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2009 Jul 14;106(28):11709-12</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19597152</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2009 Dec 15;106(50):21312-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19995968</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Commun. 2011 Jan 18;2:156</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21245837</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2011 Aug 23;108(34):14264-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21825167</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS Pathog. 2011 Dec;7(12):e1002443</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22241979</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2012 Mar 13;109(11):4269-74</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22371588</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nature. 2012 May 02;486(7403):420-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22722205</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 2012 Jun 22;336(6088):1534-41</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22723413</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS Pathog. 2013 Mar;9(3):e1003223</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23516363</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Zoonoses Public Health. 2014 Feb;61(1):4-17</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23556412</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Virus Res. 2013 Dec 5;178(1):78-98</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23726847</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS Pathog. 2013;9(10):e1003657</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24130481</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nature. 2014 Apr 10;508(7495):254-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24531761</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Curr Top Microbiol Immunol. 2014;385:359-75</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24990620</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Trends Microbiol. 2015 Mar;23(3):142-53</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25564096</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nature. 2015 Oct 1;526(7571):122-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26416728</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Future Virol. 2015;10(9):1033-1047</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26587050</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nature. 2016 Jan 7;529(7584):101-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26738596</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 1989 Nov;63(11):4603-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2795713</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Wkly Epidemiol Rec. ;92(33):460-75</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28819964</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>MBio. 2018 Jun 5;9(3):</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29871917</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Drugs. 2018 Sep;78(13):1297-1308</Citation>
<ArticleIdList><ArticleId IdType="pubmed">30088204</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Curr Opin Virol. 2018 Aug;31:9-16</Citation>
<ArticleIdList><ArticleId IdType="pubmed">30114593</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Viruses. 2018 Sep 13;10(9):</Citation>
<ArticleIdList><ArticleId IdType="pubmed">30217093</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Microbiol. 2018 Nov;3(11):1234-1242</Citation>
<ArticleIdList><ArticleId IdType="pubmed">30224800</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Rev Microbiol. 2019 Jan;17(2):67-81</Citation>
<ArticleIdList><ArticleId IdType="pubmed">30487536</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nature. 1983 Jul 7-13;304(5921):76-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">6191220</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Virology. 1993 Jun;194(2):781-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7684877</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 1993 Apr;67(4):1761-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8445709</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Virus Genes. 1995;11(2-3):209-15</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8828147</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000146 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000146 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= PandemieGrippaleV1 |flux= PubMed |étape= Curation |type= RBID |clé= pubmed:31027299 |texte= The Critical Interspecies Transmission Barrier at the Animal⁻Human Interface. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:31027299" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \ | NlmPubMed2Wicri -a PandemieGrippaleV1
![]() | This area was generated with Dilib version V0.6.34. | ![]() |